Myopia Treatment Market Report 2026

Myopia Treatment Market Report 2026
Global Outlook – By Type (Simple Myopia, High Myopia, Pathological Myopia), By Treatment (Eyeglasses, Contact Lenses, Refractive Surgery, Laser-Assisted In Situ Keratomileusis (LASIK), Photorefractive Keratectomy (PRK), Orthokeratology (Ortho-K)), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Direct Tender, Retail Sales, Other Distribution Channels), By End-User (Physician Offices, Reference Laboratories, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Myopia Treatment Market Overview
• Myopia Treatment market size has reached to $19.52 billion in 2025 • Expected to grow to $30.38 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Impact Of Rising Screen Time On The Growth Of The Market • Market Trend: Advancements In Optical Biometry For Enhanced Myopia Diagnosis And Treatment • Asia Pacific was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Myopia Treatment Market?
Myopia treatment refers to medical or corrective interventions used to manage or correct myopia, also known as nearsightedness. Myopia is a common refractive error of the eye where distant objects appear blurry, but close objects are clear. Myopia treatment's main goal is to improve vision and quality of life by correcting refractive errors. It also helps manage myopia progression, reducing reliance on corrective lenses for long-term vision health. The main types of myopia for myopia treatment are simple myopia, high myopia, and pathological myopia. Simple myopia is a condition where distant objects appear blurry due to an elongated eye or overly curved cornea, treatable with corrective lenses or refractive surgery. It used various treatments, such as eyeglasses, contact lenses, refractive surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and orthokeratology (Ortho-K), with several routes of administration, including oral, parenteral, and others. It is distributed by various distribution channels, such as direct tender, retail sales, and others, and used by several end users, including hospitals or clinical laboratories, physician offices, reference laboratories, and others.
What Is The Myopia Treatment Market Size and Share 2026?
The myopia treatment market size has grown strongly in recent years. It will grow from $19.52 billion in 2025 to $21.38 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing screen time exposure, rise in childhood myopia prevalence, limited access to preventive eye care, early development of refractive surgery techniques, initial adoption of corrective eyewear solutions.What Is The Myopia Treatment Market Growth Forecast?
The myopia treatment market size is expected to see strong growth in the next few years. It will grow to $30.38 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing awareness of myopia control therapies, expansion of laser treatment technologies, rising demand for orthokeratology, increasing investment in ophthalmic research, adoption of advanced diagnostic tools. Major trends in the forecast period include rising adoption of orthokeratology (ortho-k), increasing preference for minimally invasive refractive surgeries, growing demand for myopia control lenses in children, higher prevalence of digital eye strain-driven myopia, expansion of preventive eye care awareness programs.Global Myopia Treatment Market Segmentation
1) By Type: Simple Myopia, High Myopia, Pathological Myopia 2) By Treatment: Eyeglasses, Contact Lenses, Refractive Surgery, Laser-Assisted In Situ Keratomileusis (LASIK), Photorefractive Keratectomy (PRK), Orthokeratology (Ortho-K) 3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration 4) By Distribution Channel: Direct Tender, Retail Sales, Other Distribution Channels 5) By End-User: Physician Offices, Reference Laboratories, Other End-Users Subsegments: 1) By Simple Myopia: Mild Myopia, Moderate Myopia 2) By High Myopia: Severe Myopia, Very Severe Myopia 3) By Pathological Myopia: Degenerative Myopia, Malignant MyopiaWhat Is The Driver Of The Myopia Treatment Market?
The increase in screen time is expected to propel the growth of the myopia treatment market going forward. Screen time refers to the time a person spends using devices with screens, such as smartphones, tablets, computers, or televisions. The increase in screen time is due to the rise in streaming services, social media usage, remote work, and virtual meetings. Myopia treatment helps reduce eye strain and discomfort from prolonged screen time, improving focus and comfort and enhancing visual clarity. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, between July 2021 and December 2023, 50.4% of teenagers aged 12–17 spent 4 or more hours per day on screens, while 22.8% had 3 hours, 17.8% had 2 hours, 6.1% had 1 hour, and 3.0% spent less than 1 hour daily on screens. Therefore, the increase in screen time is driving the growth of the myopia treatment industry.Key Players In The Global Myopia Treatment Market
Major companies operating in the myopia treatment market are Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., Kubota Pharmaceutical Holdings Co. Ltd.Global Myopia Treatment Market Trends and Insights
Major companies operating in the myopia treatment market are focusing on developing advanced products such as optical biometers to enhance diagnostic precision and tailor effective, individualized treatments. Optical biometers use light to measure eye parameters, such as axial length and corneal curvature, to diagnose and monitor eye conditions. For instance, in February 2023, NIDEK Co., Ltd., a Japan-based manufacturer of ophthalmic products, launched an AL-Scan M and MV-1. This AL-Scan M device incorporates 3D auto-tracking and auto-shot functions, enabling efficient and user-friendly measurements similar to an autorefractor's. These features improve patient throughput, particularly for younger patients. The AL-Scan M is precisely engineered to provide precise axial length measurements, a critical factor in monitoring myopia progression. Additionally, it seamlessly integrates with the MV-1 Myopia Viewer software, which helps track treatment history and patient behavior.What Are Latest Mergers And Acquisitions In The Myopia Treatment Market?
In January 2023, CooperVision, Inc., a US-based manufacturer of soft contact lenses, acquired SynergEyes, Inc. for an undisclosed amount. With this acquisition, CooperVision, Inc. aims to enhance its specialty contact lens portfolio and strengthen its market position in advanced ocular care. SynergEyes, Inc. is a US-based manufacturer of specialty contact lenses for myopia progression.Regional Outlook
Asia Pacific was the largest region in the myopia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Myopia Treatment Market?
The myopia treatment market consists of revenues earned by entities by providing services such as myopia control programs, vision therapy, and lifestyle and behavioral guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The myopia treatment market includes sales of prescription glasses, atropine drops, and myopia control glasses. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Myopia Treatment Market Report 2026?
The myopia treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the myopia treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Myopia Treatment Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $21.38 billion |
| Revenue Forecast In 2035 | $30.38 billion |
| Growth Rate | CAGR of 9.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Treatment, Route Of Administration, Distribution Channel, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., Kubota Pharmaceutical Holdings Co. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Myopia Treatment market was valued at $19.52 billion in 2025, increased to $21.38 billion in 2026, and is projected to reach $30.38 billion by 2030.
request a sample hereThe global Myopia Treatment market is expected to grow at a CAGR of 9.2% from 2026 to 2035 to reach $30.38 billion by 2035.
request a sample hereSome Key Players in the Myopia Treatment market Include, Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., Kubota Pharmaceutical Holdings Co. Ltd. .
request a sample hereMajor trend in this market includes: Advancements In Optical Biometry For Enhanced Myopia Diagnosis And Treatment. For further insights on this market.
request a sample hereAsia Pacific was the largest region in the myopia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here